Significant Increase in Adjusted EBITDA
Adjusted EBITDA increased to $38 million in Q4 2024, up from $25 million in Q4 2023, despite a $7 million impact from a planned turnaround.
Record Production Rates and Safety Milestones
The Cherokee facility achieved record daily production rates for urea and UAN, and both Cherokee and Baytown facilities reported zero recordable injuries for 2024.
Strong Demand and Pricing in Industrial Markets
The company benefited from strong demand in industrial markets with increased sales volumes of ammonium nitrate solution, stable nitric acid pricing, and opportunities for future growth.
Enhanced Cash Flow and Reduced Leverage
Cash flow remains strong, with a leverage ratio below target, supported by $222 million in debt repurchases and the repurchase of 4.6 million shares over two years.